Atovaquone proguanil indications and usage

Atovaquone proguanil
MALARONE^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Indications And Usage

Prevention of Malaria

Atovaquone proguanil® is indicated for the prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported.

Treatment of Malaria

Atovaquone proguanil is indicated for the treatment of acute, uncomplicated P. falciparum malaria. Atovaquone proguanil has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.^[1]

References

↑ “MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC]”.

Adapted from the FDA Package Insert.

[dailymed.nlm.nih.gov-1] “MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC]”.

[1]

Atovaquone proguanil indications and usage

Indications And Usage

Prevention of Malaria

Treatment of Malaria

References

Looking for the patient version?